N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44%
Market Cap: 323.6B KRW
Have any thoughts about
NewGLab Pharma Co Ltd?
Write Note

NewGLab Pharma Co Ltd
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NewGLab Pharma Co Ltd
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
N
NewGLab Pharma Co Ltd
KOSDAQ:214870
Cash Interest Paid
â‚©937.1m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Vidente Co Ltd
KOSDAQ:121800
Cash Interest Paid
â‚©4B
CAGR 3-Years
51%
CAGR 5-Years
76%
CAGR 10-Years
37%
T
Tovis Co Ltd
KOSDAQ:051360
Cash Interest Paid
â‚©8.8B
CAGR 3-Years
85%
CAGR 5-Years
50%
CAGR 10-Years
24%
F
Furonteer Co Ltd
KOSDAQ:370090
Cash Interest Paid
â‚©139.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Park Systems Corp
KOSDAQ:140860
Cash Interest Paid
â‚©429.4m
CAGR 3-Years
102%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Woori Technology Inc
KOSDAQ:032820
Cash Interest Paid
â‚©2B
CAGR 3-Years
13%
CAGR 5-Years
4%
CAGR 10-Years
1%
No Stocks Found

NewGLab Pharma Co Ltd
Glance View

Market Cap
323.6B KRW
Industry
Electrical Equipment

NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
84.39 KRW
Overvaluation 99%
Intrinsic Value
Price
N

See Also

What is NewGLab Pharma Co Ltd's Cash Interest Paid?
Cash Interest Paid
937.1m KRW

Based on the financial report for Sep 30, 2024, NewGLab Pharma Co Ltd's Cash Interest Paid amounts to 937.1m KRW.

What is NewGLab Pharma Co Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
27%

Over the last year, the Cash Interest Paid growth was 153%. The average annual Cash Interest Paid growth rates for NewGLab Pharma Co Ltd have been 27% over the past three years .

Back to Top